AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Irritable Bowel Syndrome and Control Volunteers: Diet Challenge

RecruitingNAAges 18 Years - 75 YearsAllUniversity of California, Los Angeles
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study will investigate the relationship between fecal bile acids, short-chain fatty acids (SCFAs), and the gut microbiota in irritable bowel syndrome (IBS). The central hypothesis of this study is that specific shifts in the GI microbiome composition correlate with altered colonic SCFAs and BAs and contribute to IBS symptoms. Primary aims include: (a) identifying GI microbiome signatures in IBS subtypes (IBS-C and IBS-D) and matched controls, and test if microbiome signatures in these groups correlate with fecal SCFAs and bacterial fermentation of an indigestible carbohydrate (inulin) after a dietary challenge (fecal inulin), and (b) determining if GI microbiome signatures in IBS subtypes and controls correlate with fecal BAs or markers of SCFA production (fecal SCFAs or inulin) and test if BAs correlate with fecal SCFAs or inulin. The target population is adults ages 18-65 years me

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18-75 * Individuals with irritable bowel syndrome (IBS) * Healthy volunteers (healthy controls) with no prior history of gastrointestinal (GI) disease or symptoms * No dietary restrictions other than vegetarian Exclusion Criteria: * Inflammatory bowel disease, celiac disease, or certain types of abdominal cancer, as well as those with thyroid or liver issues * Abdominal surgery or abdominal radiation within 6 months of study participation, with an exception for C-section or gallbladder removal * Use of any prescription, over the counter, or herbal medications known to affect gastrointestinal function or study interpretation, such as opioids, inflammatory drugs or certain antidepressants, within 6 months prior to study participation for healthy volunteers, or within 2 days of study participation for participants with IBS. * An exception will be permitted for limited use of stable low doses of antidepressants for individuals who have been taking them for a period greater than one month. * Rescue medication such as Bisacodyl (dulcolax) to relieve severe constipation and allow for stool collection will be permitted when needed. * Use of Ozempic and Ozempic-type medications * Pregnant or breastfeeding women * Antibiotic use within 3 months of study participation * Use of prebiotics or probiotics within the 2 weeks before the study initiation * Regular tobacco use within the past 6 months
๐Ÿ’Š

What it tests

  • Inulin
๐Ÿ“

Where

1 site
University of California, Los Angeles
Los Angeles, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy